BioCatalystWatch
ACHVWorkspace / ACHV / OverviewCompany library
ACHIEVE LIFE SCIENCES, INC. logo

ACHIEVE LIFE SCIENCES, INC.

ACHIEVE LIFE SCIENCES, INC. (ACHV)

Website

Featured programme · Cytisinicline

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

Cytisinicline

α4β2 nicotinic acetylcholine receptor × 5-HT3 receptor

Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Cytisinicline

α4β2 nicotinic acetylcholine receptor × 5-HT3 receptor

Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Other pipelines

Cytisinicline

α4β2 nicotinic acetylcholine receptor × 5-HT3 receptor

Upcoming / outlook

History / paused

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ACHV PR & News

PR & News

ACHV SEC archive